Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Pathology of surgically remediable epilepsy: How to evaluate.

Authors:
Rajalakshmi Poyuran

Indian J Pathol Microbiol 2022 May;65(Supplement):S176-S188

Department of Pathology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, Kerala, India.

Epilepsy surgery is a well-established treatment modality in selected cases of medically refractory epilepsy. Advances in neuroimaging technology has greatly facilitated detection of lesions that are surgically amenable. Hippocampal sclerosis is the most common pathology encountered among specimens from epilepsy-related surgeries. Other common pathologies are malformations of cortical development including focal cortical dysplasia, neoplasms, vascular malformations, inflammatory conditions including Rasmussen encephalitis and glial scars. Proper handling of surgical specimens is necessary for microscopic evaluation. Accurate interpretation and classification of lesions will help define clinically relevant etiologies. In this review, neuropathological aspects of the common etiologies underlying drug-resistant epilepsies are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijpm.ijpm_1026_21DOI Listing
May 2022

Publication Analysis

Top Keywords

epilepsies discussed
4
cortical dysplasia
4
encephalitis glial
4
rasmussen encephalitis
4
including rasmussen
4
conditions including
4
inflammatory conditions
4
malformations inflammatory
4
vascular malformations
4
neoplasms vascular
4
dysplasia neoplasms
4
focal cortical
4
scars proper
4
including focal
4
pathology surgically
4
cortical development
4
malformations cortical
4
pathologies malformations
4
common pathologies
4
surgeries common
4

Keyword Occurance

Similar Publications

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Authors:
Antonio Gil-Nagel Mercè Falip Rocío Sánchez-Carpintero María Reyes Abad-Sazatornil José Luis Poveda José Ángel Aibar Elena Cardenal-Muñoz Luis Miguel Aras Rosa Sánchez Arantxa Sancho-López José Luis Trillo-Mata María Torrejón Alicia Gil

Epilepsy Behav 2022 May 16;132:108711. Epub 2022 May 16.

Omakase Consulting S.L., Barcelona, Spain. Electronic address:

Introduction: Dravet Syndrome (DS) is a severe, developmental epileptic encephalopathy (DEE) that begins in infancy and is characterized by pharmaco-resistant epilepsy and neurodevelopmental delay. Despite available antiseizure medications (ASMs), there is a need for new therapeutic options with greater efficacy in reducing seizure frequency and with adequate safety and tolerability profiles. Fenfluramine is a new ASM for the treatment of seizures associated with DS as add-on therapy to other ASMs for patients aged 2 years and older. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Discussion of the Brazilian neurologists about sudden unexpected death in epilepsy.

Authors:
Amanda Mosini Ively Guimarães Abdalla Michele Longoni Calió Ana Claudia Fiorini Carla Alessandra Scorza Maria Alice Susemihl Josef Finsterer Fúlvio Scorza

Rev Assoc Med Bras (1992) 2022 May;68(5):675-679

Escola Paulista de Medicina/Universidade Federal de São Paulo, Disciplina de Neurologia Experimental - São Paulo (SP), Brazil.

Objective: This study aimed to evaluate the concept of health professionals affiliated with the Brazilian League of Epilepsy on whether or not to inform patients about the risk factors related to the occurrence of sudden unexpected death in epilepsy.

Methods: A descriptive research of inquiry was conducted with direct survey on the Brazilian neurologist's view, regarding medical behavior in the health area to report or not about the risk of sudden unexpected death in epilepsy. Data collection consisted of a structured questionnaire available online. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Posterior quadrant disconnection for refractory epilepsy: how I do it.

Authors:
Sami Barrit Eun-Hyoung Park Joseph R Madsen

Acta Neurochir (Wien) 2022 May 17. Epub 2022 May 17.

Neurodynamics Laboratory, Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Background: Posterior quadrant disconnection (PQD) is intended to interrupt the propagation of intractable unilateral temporo-parieto-occipital epilepsy.

Method: An enhanced operative video presents the illustrative case of a total PQD indicated for a 15-year-old boy with Sturge-Weber syndrome suffering from seizure recurrence after a partial PQD. We describe the surgical procedure with emphasis on relevant anatomy and multimodal intraoperative guidance in three steps: (i) parieto-occipital disconnection, (ii) posterior callosotomy, and (iii) temporal disconnection/resection. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Lactate Is Answerable for Brain Function and Treating Brain Diseases: Energy Substrates and Signal Molecule.

Authors:
Ming Cai Hongbiao Wang Haihan Song Ruoyu Yang Liyan Wang Xiangli Xue Wanju Sun Jingyun Hu

Front Nutr 2022 28;9:800901. Epub 2022 Apr 28.

Central Lab, Shanghai Pudong New Area People's Hospital, Shanghai, China.

Research to date has provided novel insights into lactate's positive role in multiple brain functions and several brain diseases. Although notable controversies and discrepancies remain, the neurobiological role and the metabolic mechanisms of brain lactate have now been described. A theoretical framework on the relevance between lactate and brain function and brain diseases is presented. Read More

View Article and Full-Text PDF
April 2022
Similar Publications

Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders.

Authors:
Tejas Girish Agnihotri Govinda Shivaji Jadhav Bichismita Sahu Aakanchha Jain

Drug Deliv Transl Res 2022 May 15. Epub 2022 May 15.

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad, Palaj, Gandhinagar, 382355, Gujarat, India.

The global burden of neurological disorders has been increasing day by day which calls for immediate attention to the solutions. Novel drug delivery systems are one of the alternatives that we count on to counteract these disorders. As the blood-brain barrier creates a significant hindrance to the delivery of drugs across the endothelium lining of the brain, nose-to-brain delivery has been the favorite option to administer such drugs. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap